ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,828,000 | +84.5% | 125,790 | -2.9% | 0.01% | +100.0% |
Q1 2019 | $3,158,000 | +94.7% | 129,540 | +13.8% | 0.00% | +50.0% |
Q4 2018 | $1,622,000 | +4405.6% | 113,870 | +4725.0% | 0.00% | – |
Q3 2018 | $36,000 | -12.2% | 2,360 | -2.3% | 0.00% | – |
Q2 2018 | $41,000 | -97.1% | 2,415 | -97.2% | 0.00% | -100.0% |
Q1 2018 | $1,390,000 | +4533.3% | 85,147 | +3507.9% | 0.00% | – |
Q4 2017 | $30,000 | +3.4% | 2,360 | 0.0% | 0.00% | – |
Q3 2017 | $29,000 | -98.2% | 2,360 | -98.8% | 0.00% | -100.0% |
Q2 2017 | $1,594,000 | -11.7% | 190,488 | -5.7% | 0.00% | 0.0% |
Q1 2017 | $1,806,000 | +0.3% | 202,067 | -1.4% | 0.00% | 0.0% |
Q4 2016 | $1,801,000 | +19911.1% | 204,870 | +15659.2% | 0.00% | – |
Q3 2016 | $9,000 | +12.5% | 1,300 | -37.5% | 0.00% | – |
Q2 2016 | $8,000 | +33.3% | 2,081 | -1.4% | 0.00% | – |
Q1 2016 | $6,000 | -80.0% | 2,111 | -70.2% | 0.00% | – |
Q4 2015 | $30,000 | -9.1% | 7,083 | 0.0% | 0.00% | – |
Q3 2015 | $33,000 | -34.0% | 7,083 | +0.4% | 0.00% | – |
Q2 2015 | $50,000 | +2.0% | 7,057 | +5.2% | 0.00% | – |
Q1 2015 | $49,000 | +53.1% | 6,711 | 0.0% | 0.00% | – |
Q4 2014 | $32,000 | +39.1% | 6,711 | 0.0% | 0.00% | – |
Q3 2014 | $23,000 | -25.8% | 6,711 | 0.0% | 0.00% | – |
Q2 2014 | $31,000 | -3.1% | 6,711 | 0.0% | 0.00% | – |
Q1 2014 | $32,000 | 0.0% | 6,711 | +6.5% | 0.00% | – |
Q4 2013 | $32,000 | -17.9% | 6,300 | 0.0% | 0.00% | – |
Q3 2013 | $39,000 | +34.5% | 6,300 | 0.0% | 0.00% | – |
Q2 2013 | $29,000 | – | 6,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |